APOA1 and chronic kidney disease: CKD is further associated with carbamylation of apolipoproteins due to increased myeloperoxidase and urea-derived cyanate (30), and elevated levels of α-oxoaldehydes can covalently modify apoA-I altering the conformation of specific domains crucial for LCAT activation (31).